Shares of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) rose 12.71% to $3.37 in pre-event trading as the company’s subsidiary, HOPE Therapeutics, Inc., announced a pivotal investor
The clinical stage, pharmaceutical company, NRx (NASDAQ: NRXP) Pharmaceuticals has been the talk of the town lately. It recently saw a significant 60% surge, which
On January 07, NRx Pharmaceuticals Inc. (NRXP) announced its upcoming company updates presentation at the H.C. Wainwright BioConnect conference. The company will be discussing new
NRx Pharmaceuticals, Inc. (NRXP) stock prices skyrocketed by 42.84% shortly after market trading commenced on July 19th 2021, bringing the price per share up to
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.